A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.


Updates from The Motley Fool

Latest updates on Lexicon Pharmaceuticals from Fool.com.


Stock Performance

LXRX vs. S&P 500 | 2 Year Performance
View Interactive LXRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Lexicon Pharmaceuticals.
Current Price: $18.11
Prev Close: $17.90
Open: $18.06
Bid: $18.06
Ask: $18.08
Day's Range: $17.66 - $18.36
52wk Range: $7.65 - $19.62
Volume: 211,705
Avg Vol 1,238,656
Market Cap: $1.88B
P/E (ttm): -85.24
EPS (ttm): -$0.21
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Lexicon Pharmaceuticals.
CAPS Rating 2 out of 5
 
256 Outperform
45 Underperform
CAPS All Stars
 
54 Outperform
10 Underperform

How do you think Lexicon Pharmaceuticals will perform against the market?



You pick for Lexicon Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Lonnel Coats, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Lexicon Pharmaceuticals.

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers